Ardelyx (ARDX) is emerging as a compelling, yet risky, small-cap biotech opportunity. The company has made significant ...

There aren’t too many opportunities to buy a stock at a discount after recent drama and volatility, but the market offers such low-hanging fruit every once in a while. Most recently, an outage ...